Loss of Striatal Vesicular Monoamine Transporter Protein (VMAT2) in Human Cocaine Users
- 1 January 2003
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 160 (1), 47-55
- https://doi.org/10.1176/appi.ajp.160.1.47
Abstract
The hypothesis that human cocaine users lose vesicular monoamine transporter (VMAT2) protein was tested in striatal samples from cocaine users and age-, sex-, and postmortem interval-matched comparison subjects. Striatal samples were retrieved at autopsy; immunoblot assays were then performed by using a highly specific VMAT2 antibody. Striatal radioligand binding to VMAT2 was assessed with dihydrotetrabenazine ([(3)H]DTBZ) and dopamine levels employing high-performance liquid chromatography. Cocaine users displayed a marked reduction in VMAT2 immunoreactivity as well as reduced [(3)H]DTBZ binding and dopamine levels. It did not appear that the reduction in VMAT2 immunoreactivity was related to ethanol use, but dopamine levels were lower in subjects with only ethanol diagnoses. Subjects suffering from cocaine-induced mood disorders displayed a greater loss of VMAT2 immunoreactivity that approached significance. Human cocaine users lose VMAT2 protein, which might reflect damage to striatal dopamine fibers. These neuronal changes could play a role in causing disordered mood and motivational processes in more severely dependent patients.Keywords
This publication has 22 references indexed in Scilit:
- Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated miceSynapse, 2000
- Brain Dopamine Transporter Messenger RNA and Binding Sites in Cocaine UsersArchives of General Psychiatry, 1998
- Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victimsBrain Research, 1997
- Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine usersAnnals of Neurology, 1996
- The vesicular monoamine transporter is not regulated by dopaminergic drug treatmentsEuropean Journal of Pharmacology, 1995
- Cocaine use increases [3HWIN 35428 binding sites in human striatumBrain Research, 1993
- Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neuronsDrug and Alcohol Dependence, 1991
- Lack of long-term monoamine depletions following repeated or continuous exposure to cocaineBrain Research Bulletin, 1988
- Cocaine, in contrast to D-amphetamine, does not cause axonal terminal degeneration in neostriatum and agranular frontal cortex of long-evans ratsLife Sciences, 1988
- The regional distribution of dopamine and serotonin uptake and transmitter concentrations in the human brainNeurochemistry International, 1987